A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
about
Idiopathic pulmonary fibrosis.Non-steroid agents for idiopathic pulmonary fibrosisRegulation of pulmonary fibrosis by chemokine receptor CXCR3Classification and natural history of the idiopathic interstitial pneumoniasRegional chest wall volumes during exercise in chronic obstructive pulmonary diseasePirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyClinical trials of investigational agents for IPF: a review of a Cochrane reportThe psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature reviewPulmonary vaccination as a novel treatment for lung fibrosisUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisUpdate on therapeutic management of idiopathic pulmonary fibrosisAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementBUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisNatural killer cells in infection and inflammation of the lungOxidative stress and glutathione in TGF-beta-mediated fibrogenesisGenetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosisPredicting pulmonary fibrosis disease course from past trends in pulmonary function.Fibrocytes and the pathogenesis of diffuse parenchymal lung disease.Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitalsClinical advances in the diagnosis and therapy of the interstitial lung diseases.Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Rheumatoid arthritis-interstitial lung disease-associated mortality.Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)Advances in the management of idiopathic pulmonary fibrosis.The role of long-term doxycycline in patients of idiopathic pulmonaryfibrosis: The results of an open prospective trialLung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and managementEffect of treatment guidelines on the initial management of idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.Interferon-gamma-mediated inhibition of serum response factor-dependent smooth muscle-specific gene expressionNew therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.A critical assessment of treatment options for idiopathic pulmonary fibrosis.Pirfenidone treatment of idiopathic pulmonary fibrosis.Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema.
P2860
Q21202895-9076A2B4-8E98-4FF7-8732-0A835A99F274Q24235478-DE9A2C4E-8DC9-44C3-895F-B6F84BC02960Q24563456-A6B57B59-A1EA-4898-97B2-A5BF04337D48Q24655062-762EF148-0EB8-42DD-AF48-3B56D857FCBEQ24678673-E19DBF09-EA82-41D7-8723-94898344E02FQ26738458-A87C8221-4C0D-4EF9-A38A-DA56FD4711E6Q26823161-F060D582-7B3A-4C7F-8778-811DCE207E64Q26992007-6E32FE62-A29F-4BC6-8CCC-20FC6907C745Q27309062-9C38AF3B-27E7-4FF1-8B6D-6A34E11F167BQ28083702-BF7FB7E7-20A4-4DD7-88A9-A01FFD53D005Q28083944-660494B6-FB07-4439-8464-5BC72957DBC7Q28308246-886C9BC4-35DE-4E92-879E-1CDA871FDB85Q28308276-68B5E218-BB55-4FC9-A870-175377E24F17Q28391714-D05D2622-048C-4931-B066-1A8303378112Q28393454-35E587E4-9759-445F-A5A2-DFC2620414EFQ28943525-C96C69EE-34D4-446B-9827-6EEFC40FC645Q30370058-E2C1E68E-7651-4DC8-942B-32C87E4B4E8EQ30407660-5CD01480-A54E-46FA-B407-E22E44F16F9BQ30426516-CCD038BB-C5CF-40ED-A4BC-AC4D4EE05808Q30478617-03866E21-AD45-4211-B468-784378263F86Q30834669-2A659F43-5CE6-4324-AED3-E38527A94BAAQ33214781-DCAAAA88-BD54-4446-AD02-93871E6343FDQ33319304-FF4D3A5B-693C-44D4-A06A-2667F6971238Q33586556-673E880F-D50C-4B94-B173-20FB6AFA8BE6Q33738724-65AA6A85-3005-4755-9453-CBC9614A21BCQ33744934-DEFB4779-885B-4834-BCE6-EE6CEF98C6EEQ33766767-92E9E1D5-B513-4B6F-BB5F-1CD2D6335D71Q33814226-96286D93-293E-4EB2-8D9F-0CB9992E9E8BQ33822155-EED9EEB4-FB59-4550-84BE-B6C8C1BD83C0Q33897430-91E10B0A-543D-4978-B250-C695030F331BQ34000433-359327CB-34D2-4CC6-AC06-ACC54FD96736Q34019374-D039B8A9-8BD0-432C-B33E-9E3D81284141Q34026607-12A519FF-8EB1-4E4D-9A6E-463016C3CC47Q34186570-24F42ECF-CA11-466A-9A49-2EC6E36576C0Q34432217-20398B92-C3AC-4AD8-B8EC-F6CC7313244CQ34519796-56EEBFFA-0DA1-40CF-B129-F4B5C8116EB3Q34554406-E2D9FB27-EE0E-4C0F-845A-2B8177DA7C4DQ34562973-2DC560E9-08A1-48D3-834E-A55DBEA2C5D0Q34574174-78EEEE7E-8E07-4F16-8022-A28F1C3334B4Q34734509-ADC198E5-20AA-483B-A25B-5F4AD2ACA3FA
P2860
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@en
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@nl
type
label
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@en
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@nl
prefLabel
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@en
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@nl
P2093
P921
P356
P1476
A placebo-controlled trial of ...... idiopathic pulmonary fibrosis.
@en
P2093
David A Schwartz
Ganesh Raghu
Idiopathic Pulmonary Fibrosis Study Group
Karen Starko
Kevin K Brown
Paul W Noble
Talmadge E King
Williamson Z Bradford
P304
P356
10.1056/NEJMOA030511
P407
P577
2004-01-01T00:00:00Z